New York, March 5, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the American College of Cardiology (ACC) are pleased to announce that the American College of Cardiology (ACC) journals' portfolio has been expanded with the launch of JACC: Heart Failure. This new journal will better meet the demands and challenges of treating what is now the most rapidly increasing category of cardiac disease. The first publication is now available online at heartfailure.onlinejacc.org.
Christopher O'Connor, MD, FACC will serve as Editor-in-Chief of JACC: Heart Failure. Each bi-monthly issue will present high-quality content, authored by experts worldwide, with a unique focus on new research and treatment options. It is destined to take its place among the top journals in the world for the understanding of the pathophysiology, diagnosis, treatment, and care of heart failure patients with the intent to improve our understanding of the disease, clinical trials, clinical outcomes, and advances in therapies through scientific communication.
A state-of-the-condition update by Dr. Eugene Braunwald and the breadth of articles featured in the first issue are an example of the journal's aims to publish the full range of topics related to this condition - including basic and translational science, trials and registries, co-morbidities, biomarkers, advanced heart failure, and outcomes.
"The addition of JACC: Heart Failure to ACC's current portfolio will help meet the need for more research in this growing field," said ACC President William Zoghbi, MD, FACC. "With the increasing rate of patients suffering from heart failure, the science presented in this new journal will give cardiologists access to valuable new research."
"We are delighted to be publishing JACC: Heart Failure in collaboration with the ACC," says Cynthia Baudendistel, Executive Publisher for the ACC journals at Elsevier. "We look forward to seeing the impact this journal will make on cardiology practice, research, teaching, and advocacy."
About the American College of Cardiology (ACC)
The mission of the American College of Cardiology is to transform cardiovascular care and improve heart health. The college is a 40,000-member medical society comprised of physicians, surgeons, nurses, physician assistants, pharmacists and practice managers. The college is a leader in the formulation of health policy, standards and guidelines. The ACC provides professional education, operates national registries to measure and improve quality of care, disseminates cardiovascular research, and bestows credentials upon cardiovascular specialists who meet stringent qualifications. cardiosource.org/ACC.
About ACC's portfolio of journals
Journal of the American College of Cardiology (JACC)
As the leader in its field, JACC publishes original peer-reviewed clinical and experimental reports on all aspects of cardiovascular disease. Topics covered include coronary artery and valve disease, congenital heart defects, vascular surgery, cardiomyopathy, drug treatment, new diagnostic techniques, findings from the laboratory, and large multicenter studies of new therapies. content.onlinejacc.org
JACC: Cardiovascular Imaging
JACC: Cardiovascular Imaging provides readers with a broad, balanced view of all aspects of cardiovascular imaging. The journal includes original clinical research on non-invasive and invasive imaging techniques including echocardiography, CT, CMR, nuclear, optical imaging, and cine-angiography. Advances in basic science and molecular imaging which are likely to substantially influence the clinical practice of medicine in the next decade (in diagnostic performance, understanding of the athogenetic basis of the disease, and therapy) are also featured. Other content will emphasize imaging for the practicing cardiologist, advocacy and practice management, and state-of-the-art reviews. imaging.onlinejacc.org
JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions encompasses the entire field of interventional cardiovascular medicine, including cardiac (coronary and non-coronary) peripheral and cerebrovascular interventions. JACC: Cardiovascular Interventions publishes studies that will impact the practice of interventional cardiovascular medicine including: Clinical trials that provide evidence to inform and alter practice guidelines; experimental studies that point to improved technologies and mechanistic understanding; and in-depth discussions of topics of interest by respected experts in the field. interventions.onlinejacc.org
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).